Highly modulated EMT markers included fibulin 2 (FBLN2), a paralog of the MPM biomarker FBLN3 (43), and transglutaminase 2 (TGM2), a cancer stem cell survival protein required for MPM tumor formation (44). Here, EFEMP1 is linked to neoplasm.